Scalp application of the antioxidant piroctone olamine reduces hair shedding in an 8-week randomized, double-blind, placebo-controlled clinical study.

Autor: Davis MG; The Procter & Gamble Company, Mason, Ohio, USA., Piliang MP; Department of Dermatology, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA., Bergfeld WF; Department of Dermatology, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA., Caterino TL; The Procter & Gamble Company, Mason, Ohio, USA., Fisher BK; The Procter & Gamble Company, Mason, Ohio, USA., Sacha JP; The Procter & Gamble Company, Mason, Ohio, USA., Carr GJ; The Procter & Gamble Company, Mason, Ohio, USA., Moulton LT; The Procter & Gamble Company, Mason, Ohio, USA., Whittenbarger DJ; The Procter & Gamble Company, Mason, Ohio, USA., Punyani S; The Procter & Gamble Company, Singapore, Singapore., Schwartz JR; The Procter & Gamble Company, Mason, Ohio, USA.

Publikováno v: International journal of cosmetic science [Int J Cosmet Sci] 2021 Nov; Vol. 43 Suppl 1, pp. S26-S33.

Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24-week randomized, double-blind, placebo-controlled clinical trial.

Autor: Davis MG; The Procter & Gamble Company, Mason, Ohio, USA., Piliang MP; Department of Dermatology, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA., Bergfeld WF; Department of Dermatology, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, USA., Caterino TL; The Procter & Gamble Company, Mason, Ohio, USA., Fisher BK; The Procter & Gamble Company, Mason, Ohio, USA., Sacha JP; The Procter & Gamble Company, Mason, Ohio, USA., Carr GJ; The Procter & Gamble Company, Mason, Ohio, USA., Moulton LT; The Procter & Gamble Company, Mason, Ohio, USA., Whittenbarger DJ; The Procter & Gamble Company, Mason, Ohio, USA., Schwartz JR; The Procter & Gamble Company, Mason, Ohio, USA.

Publikováno v: International journal of cosmetic science [Int J Cosmet Sci] 2021 Nov; Vol. 43 Suppl 1, pp. S14-S25.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Oral minoxidil for late alopecia in cancer survivors.

Autor: Kuo AM; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reingold RE; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ketosugbo KF; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pan A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kraehenbuehl L; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ludwig Collaborative and Swim Across America Laboratory, Human Oncology and Pathogenesis Program, Department of Medicine, MSKCC, Parker Institute for Cancer Immunotherapy, New York, NY, USA., Dusza S; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gajria D; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lake DE; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bromberg JF; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Traina TA; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fornier MN; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gucalp A; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., D'Alessandro BM; Canfield Scientific, Inc., Parsippany, NJ, USA., Rotemberg V; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dauscher M; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shapiro J; Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, USA., Goldfarb SB; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lacouture ME; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Mario.Lacouture@nyulangone.org.; Dermatology Division, Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, New York, USA. Mario.Lacouture@nyulangone.org.; Symptom Management Program, Perlmutter Cancer Center, NYU Langone Hospital - Long Island, Mineola, New York, USA. Mario.Lacouture@nyulangone.org.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Dec; Vol. 208 (3), pp. 491-499. Date of Electronic Publication: 2024 Aug 04.

Scalp condition improvement with botanical extracts possessing chemical and physical antioxidant activity.

Autor: Marsh JM; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Li L; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Knowles S; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Locker KCS; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Pearson K; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Bacon R; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Kozak K; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Laughlin T; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA., Schwartz JR; The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA.

Publikováno v: International journal of cosmetic science [Int J Cosmet Sci] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.